Active Biotech’s SEK 55 Million Rights Offering

Vinge advised Active Biotech on the deal.Active Biotech AB (publ) (Nasdaq Stockholm) carried out a rights issue of approximately SEK 55 million. Active Biotech is a biotechnology…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now